Display options
Cite
Al-Dujaili EA, Munir N, Iniesta RR. Effect of vitamin D supplementation on cardiovascular disease risk factors and exercise performance in healthy participants: a randomized placebo-controlled preliminary study. Ther Adv Endocrinol Metab. 2016;7(4):153-65doi: 10.1177/2042018816653357.
Al-Dujaili, E. A., Munir, N., & Iniesta, R. R. (2016). Effect of vitamin D supplementation on cardiovascular disease risk factors and exercise performance in healthy participants: a randomized placebo-controlled preliminary study. Therapeutic advances in endocrinology and metabolism, 7(4), 153-65. https://doi.org/10.1177/2042018816653357
Al-Dujaili, Emad A S, et al. "Effect of vitamin D supplementation on cardiovascular disease risk factors and exercise performance in healthy participants: a randomized placebo-controlled preliminary study." Therapeutic advances in endocrinology and metabolism vol. 7,4 (2016): 153-65. doi: https://doi.org/10.1177/2042018816653357
Al-Dujaili EA, Munir N, Iniesta RR. Effect of vitamin D supplementation on cardiovascular disease risk factors and exercise performance in healthy participants: a randomized placebo-controlled preliminary study. Ther Adv Endocrinol Metab. 2016 Aug;7(4):153-65. doi: 10.1177/2042018816653357. Epub 2016 Jun 20. PMID: 27540461; PMCID: PMC4973406.
Copy Download .nbib Format: NLM
Share it on

Ther Adv Endocrinol Metab. 2016 Aug;7(4):153-65. doi: 10.1177/2042018816653357. Epub 2016 Jun 20.

Effect of vitamin D supplementation on cardiovascular disease risk factors and exercise performance in healthy participants: a randomized placebo-controlled preliminary study.

Therapeutic advances in endocrinology and metabolism

Emad A S Al-Dujaili, Nimrah Munir, Raquel Revuelta Iniesta

Affiliations

  1. Queen Margaret University, Queen Margaret University Drive, Musselburgh, Edinburgh, East Lothian EH21 6UU, UK.
  2. Dietetics, Nutrition and Biological Sciences, Queen Margaret University, Edinburgh, UK.

PMID: 27540461 PMCID: PMC4973406 DOI: 10.1177/2042018816653357

Abstract

BACKGROUND AND OBJECTIVES: Evidence suggests associations between vitamin D deficiency and cardiovascular disease (CVD) risk factors, including hypertension and excessive cortisol levels. Also, vitamin D levels may impact exercise performance. Thus, we aimed to investigate the effects of vitamin D intake on cardiovascular risk factors, free urinary cortisol and exercise performance.

METHODS: A randomized placebo-controlled single-blinded parallel trial was conducted in healthy participants (n = 15). They received 2000 IU (50 µg) vitamin D3 per day (n = 9) or placebo (lactose) (n = 6) for 14 days. Body composition, systolic blood pressure (SBP), diastolic blood pressure (DBP) and arterial elasticity (as measured by pulse wave velocity, PWV) were recorded at baseline, day 7 and day 14 of intervention. A total of two 24-hour urine samples were collected to estimate free cortisol and cortisone levels. Exercise performance was assessed at the baseline and day 14 of the intervention using a bike ergometer in which BP and PWV were measured before and after exercise. The distance cycled in 20 minutes and the Borg Scale rate of perceived exertion (RPE) were recorded.

RESULTS: In the intervention arm, at day 14, vitamin D supplementation significantly reduced SBP and DBP from 115.8 ± 17.1 and 75.4 ± 10.3 at baseline to 106.3 ± 10.9 (p = 0.022) and 68.5 ± 10.1 mmHg (p = 0.012) respectively. Also arterial stiffness was markedly reduced in the vitamin D group (from 7.45 ± 1.55 to 6.11 ± 1.89, p = 0.049). Urinary free cortisol levels and cortisol/cortisone ratio were significantly reduced from 162.65 ± 58.9 nmol/day and 2.22 ± 0.7 to 96.4 ± 37.2 (p = 0.029) and 1.04 ± 0.4 (p = 0.017) respectively. Exercise-induced SBP and DBP were significantly reduced post vitamin D intake from 130.7 ± 12.2 to 116.1 ± 8.1 (p = 0.012) and from 76.2 ± 8.4 to 70.5 ± 7.7 mmHg (p = 0.042) respectively. The distance cycled in 20 minutes significantly increased from 4.98 ± 2.65 to 6.51 ± 2.28km (p = 0.020), while the Borg Scale RPE reduced from 5.13 ± 1.36 to 4.25 ± 0.71 RPE (p = 0.021). In the placebo arm, no significant effects on CVD risk factors and exercise performance were observed.

CONCLUSION: These results suggest that daily vitamin D supplementation may ameliorate CVD risk factors including a decrease in 11β-HSD1 activity, as evidenced by the decrease in the cortisol/cortisone ratio, and improve exercise performance in healthy individuals. However, large scale studies are required to verify our findings.

Keywords: blood pressure; cardiovascular disease; exercise performance; oxidative stress; pulse wave velocity; vitamin D

References

  1. J Sci Med Sport. 2014 Jan;17(1):8-12 - PubMed
  2. Am J Clin Nutr. 2009 May;89(5):1321-7 - PubMed
  3. J Clin Endocrinol Metab. 2003 Jun;88(6):2384-92 - PubMed
  4. Methods Enzymol. 1984;105:328-31 - PubMed
  5. Health (Irvine Calif). 2014 Jun;6(12):1503-1511 - PubMed
  6. Redox Biol. 2013 Oct 08;1:483-91 - PubMed
  7. Adv Exp Med Biol. 1994;366:43-58 - PubMed
  8. J Hypertens. 2009 Aug;27(8):1624-30 - PubMed
  9. J Clin Endocrinol Metab. 2010 Nov;95(11):4959-64 - PubMed
  10. Med Sci Sports Exerc. 1982;14(5):377-81 - PubMed
  11. South Med J. 2010 Aug;103(8):729-37 - PubMed
  12. J Clin Endocrinol Metab. 2010 Oct;95(10 ):4584-91 - PubMed
  13. Steroids. 2012 May;77(6):703-9 - PubMed
  14. Eur Heart J. 2009 May;30(9):1142-50 - PubMed
  15. Hypertension. 2008 Apr;51(4):1073-9 - PubMed
  16. Aging (Albany NY). 2015 Apr;7(4):269-79 - PubMed
  17. Korean J Intern Med. 2014 Sep;29(5):620-9 - PubMed
  18. J Sports Sci. 2013;31(4):344-53 - PubMed
  19. Atherosclerosis. 2009 Jul;205(1):255-60 - PubMed
  20. J Clin Endocrinol Metab. 2012 Oct;97(10):3717-23 - PubMed
  21. PLoS One. 2014 Jul 03;9(7):e101659 - PubMed
  22. Am Heart J. 2010 Nov;160(5):893-9 - PubMed
  23. Strahlentherapie. 1952;88(3-4):563-6 - PubMed
  24. J Clin Invest. 2002 Jul;110(2):229-38 - PubMed
  25. P R Health Sci J. 2012 Sep;31(3):123-9 - PubMed
  26. Chest. 1987 Jul;92(1):57-62 - PubMed
  27. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):445-7 - PubMed
  28. Eur J Heart Fail. 2012 Apr;14(4):357-66 - PubMed
  29. J Clin Endocrinol Metab. 2009 Oct;94(10):4023-30 - PubMed
  30. Am J Cardiol. 2010 Oct 1;106(7):963-8 - PubMed
  31. J Am Coll Cardiol. 2011 Jul 5;58(2):186-92 - PubMed
  32. J Nutr. 2005 Feb;135(2):317-22 - PubMed
  33. Nutr Metab Cardiovasc Dis. 2012 Apr;22(4):376-82 - PubMed
  34. J Clin Endocrinol Metab. 2009 Feb;94(2):559-63 - PubMed
  35. J Clin Endocrinol Metab. 2011 May;96(5):1478-85 - PubMed
  36. Br J Nutr. 2005 Oct;94(4):483-92 - PubMed
  37. Hypertension. 2013 Apr;61(4):779-85 - PubMed
  38. Am J Clin Nutr. 1991 Oct;54(4):684-8 - PubMed
  39. Nutr Metab Cardiovasc Dis. 2012 Oct;22(10):864-70 - PubMed
  40. Int J Sports Med. 2001 Oct;22(7):537-43 - PubMed
  41. FEBS Lett. 1993 Jul 12;326(1-3):285-8 - PubMed
  42. J Steroid Biochem Mol Biol. 2005 Oct;97(1-2):13-9 - PubMed
  43. PLoS One. 2012;7(5):e36617 - PubMed
  44. J Appl Physiol (1985). 2011 Nov;111(5):1372-9 - PubMed
  45. J Am Coll Cardiol. 1999 May;33(6):1602-9 - PubMed
  46. J Strength Cond Res. 2015 Sep;29(9):2513-21 - PubMed
  47. J Atheroscler Thromb. 2012;19(10):924-31 - PubMed
  48. BMC Med Res Methodol. 2003 Oct 27;3:22 - PubMed
  49. J Am Soc Hypertens. 2015 Mar;9(3):176-83 - PubMed
  50. Ann Intern Med. 1986 Nov;105(5):649-54 - PubMed
  51. Am J Clin Nutr. 2007 Mar;85(3):860-8 - PubMed
  52. Int J Cardiol. 2013 Aug 10;167(3):745-9 - PubMed
  53. Circulation. 2008 Jan 29;117(4):503-11 - PubMed
  54. Biochemistry (Mosc). 1997 Jun;62(6):609-12 - PubMed

Publication Types